Article
Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral Strategy
2025-11-15
Abstract excerpt
Although therapeutic drugs targeting gasdermin (GSDM)-mediated pyroptosis have made remarkable progress in treating various diseases, their potential for antiviral therapy remains largely unexplored. Inspired by the autoinhibitory mechanism of GSDM proteins and the clinical success of mRNA vaccines, herein we propose a concept of viral protease-initiated pyroptosis (VIP) mRNA therapy as a universal antiviral strat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8358c34-e57d-53c0-a65c-dcaa32dd0abb
- DOI
- 10.1101/2025.11.14.688189
